Research Report Screener Results

Chart, Financials, Historical Prices, Industry, Messages, News, Profile, Reports, more...

Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 22-May-2013
New Screen

All Reports | Brokerage Reports | Independent Reports

All Reports (Showing 1 to 10 of 10)

Release
Date Contributor Author Title Pages Price StarMine Author Rating More Info

EPS Accuracy * Portfolio Return **
22-May-13 ValuEngine, Inc. N/A ValuEngine Industry Report for Medical-biomed/genetics 18 $207 View Abstract
20-May-13 Market Edge N/A Market Edge Equity Research Report 4 $10 View Abstract
18-May-13 Pechala's Reports Frantisek Pechala ONCOLYTICS BIOTECH INC (ONCY) 12-months forecast 1 $15 View Abstract
16-May-13 ValuEngine, Inc. N/A ValuEngine Detailed Valuation Report for ONCY 11 $126.50 View Abstract
13-May-13 Zacks Investment Research Inc. N/A ONCOLYTICS BIO (ONCY) Zacks Company Snapshot 1 $11.50 View Abstract
11-May-13 S&P Capital IQ Quantitative Report N/A Oncolytics Biotech 5 $57.50 View Abstract
9-May-13 Zacks Investment Research Inc. N/A ONCOLYTICS BIO (ONCY) Zacks Company Snapshot 1 $11.50 View Abstract
8-May-13 Edison Investment Research Mr. Robin Davison, Dr. Mick Cooper TRANSGENE - KEY TIME APPROACHES 12 $10 View Abstract
2-May-13 Zacks Investment Research Inc. N/A ONCOLYTICS BIO (ONCY) Zacks Company Snapshot 1 $11.50 View Abstract
17-Apr-13 Zacks Investment Research Inc. N/A ONCOLYTICS BIO (ONCY) Zacks Company Snapshot 1 $11.50 View Abstract

Independent Reports (Showing 1 to 10 of 10)

Release
Date Contributor Author Title Pages Price More Info
22-May-13 ValuEngine, Inc. N/A ValuEngine Industry Report for Medical-biomed/genetics 18 $207 View Abstract
20-May-13 Market Edge N/A Market Edge Equity Research Report 4 $10 View Abstract
18-May-13 Pechala's Reports Frantisek Pechala ONCOLYTICS BIOTECH INC (ONCY) 12-months forecast 1 $15 View Abstract
16-May-13 ValuEngine, Inc. N/A ValuEngine Detailed Valuation Report for ONCY 11 $126.50 View Abstract
13-May-13 Zacks Investment Research Inc. N/A ONCOLYTICS BIO (ONCY) Zacks Company Snapshot 1 $11.50 View Abstract
11-May-13 S&P Capital IQ Quantitative Report N/A Oncolytics Biotech 5 $57.50 View Abstract
9-May-13 Zacks Investment Research Inc. N/A ONCOLYTICS BIO (ONCY) Zacks Company Snapshot 1 $11.50 View Abstract
8-May-13 Edison Investment Research Mr. Robin Davison, Dr. Mick Cooper TRANSGENE - KEY TIME APPROACHES 12 $10 View Abstract
2-May-13 Zacks Investment Research Inc. N/A ONCOLYTICS BIO (ONCY) Zacks Company Snapshot 1 $11.50 View Abstract
17-Apr-13 Zacks Investment Research Inc. N/A ONCOLYTICS BIO (ONCY) Zacks Company Snapshot 1 $11.50 View Abstract

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.